RECRUITING

Social Media Use in Adolescent Diabetes Care

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to evaluate the feasibility of a social media intervention to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to receive diabetes education and peer support over Instagram or to usual outpatient diabetes care. Researchers will assess whether the social media intervention is feasible. In addition, the study team will also explore and compare changes in glucose levels and person-reported outcomes between the two groups.

Official Title

Social Media Use in Adolescent Diabetes Care

Quick Facts

Study Start:2023-10-23
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06085339

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosed with type 1 diabetes ≥12 months
  2. * Most recent hemoglobin A1c (HbA1c) level is \> 7.0%
  3. * Currently use Dexcom continuous glucose monitoring (CGM) system
  4. * Speak English fluently
  5. * Cognitively able to participate in program on Instagram and complete surveys
  6. * Have access to a personal Instagram account
  7. * Found to be eligible on the Social Media Preference Screener
  1. * Patient is a ward of the state
  2. * Patient is pregnant as diabetes standard of care is different during pregnancy (i.e., different glycemic targets and frequency of clinic visits)
  3. * Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes

Contacts and Locations

Study Contact

Faisal S Malik, MD, MSHS
CONTACT
206-987-0121
faisal.malik@seattlechildrens.org

Principal Investigator

Faisal S Malik, MD, MSHS
PRINCIPAL_INVESTIGATOR
Seattle Children's Hospital

Study Locations (Sites)

Seattle Children's Hospital
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: Seattle Children's Hospital

  • Faisal S Malik, MD, MSHS, PRINCIPAL_INVESTIGATOR, Seattle Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-23
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2023-10-23
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Type 1 Diabetes